Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-related Toxicity”

200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 200 results

Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Not applicableEnded earlyNCT02370264
What this trial is testing

Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer

Who this might be right for
Musculoskeletal ComplicationRecurrent Breast CarcinomaStage IA Breast Cancer+8 more
University of Southern California 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04469075
What this trial is testing

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

Who this might be right for
GlioblastomaRecurrent GlioblastomaSkin Toxicity
Memorial Sloan Kettering Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05000710
What this trial is testing

Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy

Who this might be right for
Metastatic or Locally Advanced NSCLC
Sheba Medical Center 29
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Not applicableStudy completedNCT00902980
What this trial is testing

Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 264
Not applicableStudy completedNCT02109549
What this trial is testing

Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.

Who this might be right for
Non Small Cell Lung Cancer
Maastricht Radiation Oncology 70
Early research (Phase 1)UnknownNCT00960167
What this trial is testing

A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00019864
What this trial is testing

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Large-scale testing (Phase 3)Study completedNCT00017004
What this trial is testing

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Who this might be right for
AnemiaCervical AdenocarcinomaCervical Adenosquamous Carcinoma+6 more
Gynecologic Oncology Group 114
Early research (Phase 1)Study completedNCT00003294
What this trial is testing

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 24
Large-scale testing (Phase 3)Ended earlyNCT05128773
What this trial is testing

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity

Who this might be right for
Breast Cancer
Sanofi 3
Not applicableStudy completedNCT05403736
What this trial is testing

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Who this might be right for
Cancer
Cedars-Sinai Medical Center 20
Not applicableNot Yet RecruitingNCT07008027
What this trial is testing

Real World Asparaginase Therapy Toxicity

Who this might be right for
Drug Toxicity
St. Jude Children's Research Hospital 200
Not applicableLooking for participantsNCT06664528
What this trial is testing

Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies

Who this might be right for
Cardiac ToxicityCancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Load More Results